25 XP   0   0   10

Bionime Corp
Buy, Hold or Sell?

Let's analyse Bionime together

PenkeI guess you are interested in Bionime Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bionime Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bionime Corp

I send you an email if I find something interesting about Bionime Corp.

Quick analysis of Bionime (30 sec.)










What can you expect buying and holding a share of Bionime? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
70.0%

What is your share worth?

Current worth
NT$32.77
Expected worth in 1 year
NT$31.34
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
NT$-1.44
Return On Investment
-2.0%

For what price can you sell your share?

Current Price per Share
NT$70.50
Expected price per share
NT$67.20 - NT$73.70
How sure are you?
50%

1. Valuation of Bionime (5 min.)




Live pricePrice per Share (EOD)

NT$70.50

Intrinsic Value Per Share

NT$-73.86 - NT$91.63

Total Value Per Share

NT$-41.09 - NT$124.41

2. Growth of Bionime (5 min.)




Is Bionime growing?

Current yearPrevious yearGrowGrow %
How rich?$62.3m$63.6m-$2.1m-3.4%

How much money is Bionime making?

Current yearPrevious yearGrowGrow %
Making money$48.5k$712.2k-$663.6k-1,366.0%
Net Profit Margin0.3%4.1%--

How much money comes from the company's main activities?

3. Financial Health of Bionime (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#116 / 173

Most Revenue
#122 / 173

Most Profit
#106 / 173

Most Efficient
#107 / 173

What can you expect buying and holding a share of Bionime? (5 min.)

Welcome investor! Bionime's management wants to use your money to grow the business. In return you get a share of Bionime.

What can you expect buying and holding a share of Bionime?

First you should know what it really means to hold a share of Bionime. And how you can make/lose money.

Speculation

The Price per Share of Bionime is NT$70.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionime.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionime, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$32.77. Based on the TTM, the Book Value Change Per Share is NT$-0.36 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionime.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.010.0%0.000.0%0.010.0%0.010.0%0.010.0%
Usd Book Value Change Per Share0.020.0%-0.010.0%0.000.0%0.000.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.050.1%0.040.1%0.050.1%
Usd Total Gains Per Share0.020.0%-0.010.0%0.050.1%0.040.1%0.060.1%
Usd Price Per Share2.34-2.37-2.35-2.19-1.99-
Price to Earnings Ratio99.32--26.47-65.96-29.30-53.66-
Price-to-Total Gains Ratio141.42--3,687.72-93.66--716.15--321.73-
Price to Book Ratio2.28-2.34-2.24-2.12-2.10-
Price-to-Total Gains Ratio141.42--3,687.72-93.66--716.15--321.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.20665
Number of shares453
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.04
Gains per Quarter (453 shares)-5.0919.60
Gains per Year (453 shares)-20.3678.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-20-3078068
20-41-501570146
30-61-702350224
40-81-903140302
50-102-1103920380
60-122-1304700458
70-143-1505490536
80-163-1706270614
90-183-1907060692
100-204-2107840770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%16.04.00.080.0%36.04.00.090.0%50.04.00.092.6%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%26.014.00.065.0%38.016.00.070.4%
Dividend per Share0.00.04.00.0%7.00.05.058.3%14.00.06.070.0%28.00.012.070.0%34.00.020.063.0%
Total Gains per Share2.02.00.050.0%10.02.00.083.3%17.03.00.085.0%33.07.00.082.5%45.09.00.083.3%

Fundamentals of Bionime

About Bionime Corp

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors and self-monitors, as well as accessories, such as test strips and lancing devices for hospital and clinical use. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.

Fundamental data was last updated by Penke on 2024-03-26 08:25:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bionime Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bionime earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 2.3% means that NT$0.02 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionime Corp:

  • The MRQ is 2.3%. The company is making a profit. +1
  • The TTM is 0.3%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM0.3%+2.1%
TTM0.3%YOY4.1%-3.8%
TTM0.3%5Y3.2%-3.0%
5Y3.2%10Y4.9%-1.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%6.2%-3.9%
TTM0.3%7.4%-7.1%
YOY4.1%8.0%-3.9%
5Y3.2%7.1%-3.9%
10Y4.9%7.7%-2.8%
1.1.2. Return on Assets

Shows how efficient Bionime is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • 0.2% Return on Assets means that Bionime generated NT$0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionime Corp:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.0%+0.2%
TTM0.0%YOY0.5%-0.4%
TTM0.0%5Y0.4%-0.4%
5Y0.4%10Y0.5%-0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%1.2%-1.0%
TTM0.0%1.2%-1.2%
YOY0.5%1.7%-1.2%
5Y0.4%1.6%-1.2%
10Y0.5%1.6%-1.1%
1.1.3. Return on Equity

Shows how efficient Bionime is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • 0.6% Return on Equity means Bionime generated NT$0.01 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionime Corp:

  • The MRQ is 0.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.1%+0.5%
TTM0.1%YOY1.1%-1.0%
TTM0.1%5Y0.9%-0.8%
5Y0.9%10Y1.2%-0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%2.3%-1.7%
TTM0.1%2.6%-2.5%
YOY1.1%3.1%-2.0%
5Y0.9%3.2%-2.3%
10Y1.2%3.0%-1.8%

1.2. Operating Efficiency of Bionime Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bionime is operating .

  • Measures how much profit Bionime makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionime Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.9%-3.9%
TTM-5Y5.3%-5.3%
5Y5.3%10Y5.6%-0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-6.4%-6.4%
YOY3.9%10.7%-6.8%
5Y5.3%10.0%-4.7%
10Y5.6%8.4%-2.8%
1.2.2. Operating Ratio

Measures how efficient Bionime is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are NT$1.61 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Bionime Corp:

  • The MRQ is 1.614. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.621. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.614TTM1.621-0.007
TTM1.621YOY1.475+0.146
TTM1.6215Y1.537+0.084
5Y1.53710Y1.210+0.327
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6141.099+0.515
TTM1.6211.149+0.472
YOY1.4751.109+0.366
5Y1.5371.101+0.436
10Y1.2101.055+0.155

1.3. Liquidity of Bionime Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bionime is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.01 means the company has NT$1.01 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionime Corp:

  • The MRQ is 1.005. The company is just able to pay all its short-term debts.
  • The TTM is 0.991. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.005TTM0.991+0.014
TTM0.991YOY1.013-0.022
TTM0.9915Y1.073-0.082
5Y1.07310Y0.775+0.298
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0052.385-1.380
TTM0.9912.589-1.598
YOY1.0132.582-1.569
5Y1.0732.635-1.562
10Y0.7752.614-1.839
1.3.2. Quick Ratio

Measures if Bionime is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.36 means the company can pay off NT$0.36 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionime Corp:

  • The MRQ is 0.355. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.341. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.355TTM0.341+0.014
TTM0.341YOY0.416-0.075
TTM0.3415Y0.395-0.054
5Y0.39510Y0.351+0.044
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3551.165-0.810
TTM0.3411.172-0.831
YOY0.4161.283-0.867
5Y0.3951.392-0.997
10Y0.3511.477-1.126

1.4. Solvency of Bionime Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bionime assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bionime to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.62 means that Bionime assets are financed with 62.4% credit (debt) and the remaining percentage (100% - 62.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bionime Corp:

  • The MRQ is 0.624. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.613. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.624TTM0.613+0.011
TTM0.613YOY0.587+0.026
TTM0.6135Y0.567+0.046
5Y0.56710Y0.569-0.002
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6240.353+0.271
TTM0.6130.355+0.258
YOY0.5870.358+0.229
5Y0.5670.362+0.205
10Y0.5690.369+0.200
1.4.2. Debt to Equity Ratio

Measures if Bionime is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 166.5% means that company has NT$1.67 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionime Corp:

  • The MRQ is 1.665. The company is just able to pay all its debts with equity.
  • The TTM is 1.591. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.665TTM1.591+0.074
TTM1.591YOY1.425+0.166
TTM1.5915Y1.327+0.264
5Y1.32710Y1.444-0.117
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6650.541+1.124
TTM1.5910.545+1.046
YOY1.4250.529+0.896
5Y1.3270.640+0.687
10Y1.4440.665+0.779

2. Market Valuation of Bionime Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Bionime generates.

  • Above 15 is considered overpriced but always compare Bionime to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 99.32 means the investor is paying NT$99.32 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionime Corp:

  • The EOD is 93.612. Based on the earnings, the company is expensive. -2
  • The MRQ is 99.322. Based on the earnings, the company is expensive. -2
  • The TTM is -26.467. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD93.612MRQ99.322-5.710
MRQ99.322TTM-26.467+125.789
TTM-26.467YOY65.963-92.430
TTM-26.4675Y29.303-55.770
5Y29.30310Y53.658-24.355
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD93.61217.153+76.459
MRQ99.32218.041+81.281
TTM-26.46719.435-45.902
YOY65.96320.661+45.302
5Y29.30321.526+7.777
10Y53.65827.509+26.149
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionime Corp:

  • The EOD is -12.875. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.661. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.243. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.875MRQ-13.661+0.785
MRQ-13.661TTM-3.243-10.418
TTM-3.243YOY-26.827+23.584
TTM-3.2435Y-11.736+8.493
5Y-11.73610Y-74.209+62.473
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-12.87510.417-23.292
MRQ-13.66110.581-24.242
TTM-3.2431.298-4.541
YOY-26.8274.650-31.477
5Y-11.7364.114-15.850
10Y-74.2090.108-74.317
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bionime is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.28 means the investor is paying NT$2.28 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionime Corp:

  • The EOD is 2.151. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.282. Based on the equity, the company is underpriced. +1
  • The TTM is 2.340. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.151MRQ2.282-0.131
MRQ2.282TTM2.340-0.058
TTM2.340YOY2.240+0.100
TTM2.3405Y2.117+0.223
5Y2.11710Y2.103+0.015
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.1512.531-0.380
MRQ2.2822.733-0.451
TTM2.3402.706-0.366
YOY2.2403.244-1.004
5Y2.1173.824-1.707
10Y2.1034.219-2.116
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bionime Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.529-0.359+168%0.018+2786%0.000+684326%0.379+39%
Book Value Per Share--32.77232.331+1%33.441-2%33.078-1%31.930+3%
Current Ratio--1.0050.991+1%1.013-1%1.073-6%0.775+30%
Debt To Asset Ratio--0.6240.613+2%0.587+6%0.567+10%0.569+10%
Debt To Equity Ratio--1.6651.591+5%1.425+17%1.327+25%1.444+15%
Dividend Per Share----0%1.495-100%1.382-100%1.629-100%
Eps--0.1880.026+638%0.374-50%0.290-35%0.394-52%
Free Cash Flow Per Share---1.369-0.978-29%-0.701-49%-0.193-86%0.585-334%
Free Cash Flow To Equity Per Share---1.369-0.978-29%-0.234-83%-0.355-74%0.402-441%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--91.635--------
Intrinsic Value_10Y_min---73.858--------
Intrinsic Value_1Y_max--3.334--------
Intrinsic Value_1Y_min---3.204--------
Intrinsic Value_3Y_max--14.475--------
Intrinsic Value_3Y_min---13.319--------
Intrinsic Value_5Y_max--30.990--------
Intrinsic Value_5Y_min---27.403--------
Market Cap4287810000.000-6%4549336000.0004601033000.000-1%4556938500.0000%4263225963.000+7%3878839840.800+17%
Net Profit Margin--0.0230.003+774%0.041-42%0.032-27%0.049-52%
Operating Margin----0%0.039-100%0.053-100%0.056-100%
Operating Ratio--1.6141.6210%1.475+9%1.537+5%1.210+33%
Pb Ratio2.151-6%2.2822.340-2%2.240+2%2.117+8%2.103+9%
Pe Ratio93.612-6%99.322-26.467+127%65.963+51%29.303+239%53.658+85%
Price Per Share70.500-6%74.80075.650-1%74.9250%70.055+7%63.598+18%
Price To Free Cash Flow Ratio-12.875+6%-13.661-3.243-76%-26.827+96%-11.736-14%-74.209+443%
Price To Total Gains Ratio133.294-6%141.424-3687.718+2708%93.662+51%-716.145+606%-321.732+327%
Quick Ratio--0.3550.341+4%0.416-15%0.395-10%0.351+1%
Return On Assets--0.0020.000+665%0.005-53%0.004-44%0.005-60%
Return On Equity--0.0060.001+652%0.011-49%0.009-34%0.012-52%
Total Gains Per Share--0.529-0.359+168%1.513-65%1.382-62%2.009-74%
Usd Book Value--62387222.60061546927.150+1%63661015.225-2%63005823.280-1%60993180.070+2%
Usd Book Value Change Per Share--0.017-0.011+168%0.001+2786%0.000+684326%0.012+39%
Usd Book Value Per Share--1.0261.012+1%1.047-2%1.035-1%0.999+3%
Usd Dividend Per Share----0%0.047-100%0.043-100%0.051-100%
Usd Eps--0.0060.001+638%0.012-50%0.009-35%0.012-52%
Usd Free Cash Flow---2605912.800-1861990.050-29%-1335171.925-49%-367438.525-86%1131716.448-330%
Usd Free Cash Flow Per Share---0.043-0.031-29%-0.022-49%-0.006-86%0.018-334%
Usd Free Cash Flow To Equity Per Share---0.043-0.031-29%-0.007-83%-0.011-74%0.013-441%
Usd Market Cap134208453.000-6%142394216.800144012332.900-1%142632175.0500%133438972.642+7%121407687.017+17%
Usd Price Per Share2.207-6%2.3412.368-1%2.3450%2.193+7%1.991+18%
Usd Profit--358416.30048585.425+638%712270.625-50%552975.535-35%753445.775-52%
Usd Revenue--15326264.10013737311.775+12%17297858.925-11%15114126.785+1%14366523.155+7%
Usd Total Gains Per Share--0.017-0.011+168%0.047-65%0.043-62%0.063-74%
 EOD+3 -5MRQTTM+21 -11YOY+4 -315Y+8 -2710Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of Bionime Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1593.612
Price to Book Ratio (EOD)Between0-12.151
Net Profit Margin (MRQ)Greater than00.023
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.355
Current Ratio (MRQ)Greater than11.005
Debt to Asset Ratio (MRQ)Less than10.624
Debt to Equity Ratio (MRQ)Less than11.665
Return on Equity (MRQ)Greater than0.150.006
Return on Assets (MRQ)Greater than0.050.002
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Bionime Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.605
Ma 20Greater thanMa 5070.720
Ma 50Greater thanMa 10071.314
Ma 100Greater thanMa 20074.033
OpenGreater thanClose69.700
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets5,300,575
Total Liabilities3,307,373
Total Stockholder Equity1,986,032
 As reported
Total Liabilities 3,307,373
Total Stockholder Equity+ 1,986,032
Total Assets = 5,300,575

Assets

Total Assets5,300,575
Total Current Assets1,617,238
Long-term Assets3,683,337
Total Current Assets
Cash And Cash Equivalents 391,821
Short-term Investments 57,392
Net Receivables 514,023
Inventory 491,259
Other Current Assets 26,965
Total Current Assets  (as reported)1,617,238
Total Current Assets  (calculated)1,481,460
+/- 135,778
Long-term Assets
Property Plant Equipment 2,849,230
Long-term Assets Other 31,483
Long-term Assets  (as reported)3,683,337
Long-term Assets  (calculated)2,880,713
+/- 802,624

Liabilities & Shareholders' Equity

Total Current Liabilities1,609,001
Long-term Liabilities1,698,372
Total Stockholder Equity1,986,032
Total Current Liabilities
Short Long Term Debt 1,109,964
Accounts payable 147,685
Other Current Liabilities 8,072
Total Current Liabilities  (as reported)1,609,001
Total Current Liabilities  (calculated)1,265,721
+/- 343,280
Long-term Liabilities
Long term Debt 1,686,997
Capital Lease Obligations Min Short Term Debt20,235
Long-term Liabilities Other 558
Long-term Liabilities  (as reported)1,698,372
Long-term Liabilities  (calculated)1,707,790
+/- 9,418
Total Stockholder Equity
Retained Earnings 146,071
Total Stockholder Equity (as reported)1,986,032
Total Stockholder Equity (calculated)146,071
+/- 1,839,961
Other
Capital Stock614,752
Net Debt 2,405,140
Net Invested Capital 4,782,993
Net Working Capital 8,237
Property Plant and Equipment Gross 2,849,230



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302009-06-30
> Total Assets 
720,247
1,036,796
937,342
1,287,061
1,521,668
1,718,229
2,976,382
2,850,981
3,647,778
3,678,654
3,618,230
3,632,175
3,855,043
4,060,424
4,331,319
4,524,244
4,334,251
4,399,125
4,401,694
4,667,104
4,024,514
4,104,069
4,126,107
4,567,244
4,379,660
4,528,493
4,392,654
4,646,531
4,392,934
4,382,040
4,491,874
4,374,916
4,312,269
4,160,351
4,299,128
4,589,404
4,445,440
4,365,592
4,408,778
4,404,240
4,303,015
4,420,967
4,496,925
4,485,052
4,512,213
4,461,112
4,559,191
4,563,882
4,796,974
4,964,475
4,939,442
4,983,061
4,947,541
5,007,041
5,081,580
5,300,575
5,300,5755,081,5805,007,0414,947,5414,983,0614,939,4424,964,4754,796,9744,563,8824,559,1914,461,1124,512,2134,485,0524,496,9254,420,9674,303,0154,404,2404,408,7784,365,5924,445,4404,589,4044,299,1284,160,3514,312,2694,374,9164,491,8744,382,0404,392,9344,646,5314,392,6544,528,4934,379,6604,567,2444,126,1074,104,0694,024,5144,667,1044,401,6944,399,1254,334,2514,524,2444,331,3194,060,4243,855,0433,632,1753,618,2303,678,6543,647,7782,850,9812,976,3821,718,2291,521,6681,287,061937,3421,036,796720,247
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,745,884
1,501,045
1,517,685
1,579,556
1,489,277
1,488,284
1,318,438
1,447,623
1,769,945
1,623,586
1,556,853
1,618,809
1,595,432
1,374,671
1,466,278
1,491,277
1,457,309
1,455,428
1,365,212
1,434,533
1,389,717
1,585,024
1,738,651
1,680,023
1,636,615
1,483,791
1,525,231
1,515,163
1,617,238
1,617,2381,515,1631,525,2311,483,7911,636,6151,680,0231,738,6511,585,0241,389,7171,434,5331,365,2121,455,4281,457,3091,491,2771,466,2781,374,6711,595,4321,618,8091,556,8531,623,5861,769,9451,447,6231,318,4381,488,2841,489,2771,579,5561,517,6851,501,0451,745,884000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
588,877
377,873
301,765
297,479
174,348
245,504
305,767
306,692
433,631
368,537
396,919
421,563
359,558
301,284
415,011
424,077
343,247
377,150
277,896
296,031
253,085
345,202
369,430
276,259
214,489
268,706
272,945
314,936
391,821
391,821314,936272,945268,706214,489276,259369,430345,202253,085296,031277,896377,150343,247424,077415,011301,284359,558421,563396,919368,537433,631306,692305,767245,504174,348297,479301,765377,873588,877000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,484
9,024
9,232
14,343
16,194
42,687
20,440
22,859
22,429
23,445
48,940
40,087
56,050
58,245
57,751
59,162
59,825
62,737
63,176
64,810
63,388
67,692
64,326
58,992
57,392
57,39258,99264,32667,69263,38864,81063,17662,73759,82559,16257,75158,24556,05040,08748,94023,44522,42922,85920,44042,68716,19414,3439,2329,0249,4840000000000000000000000000000000
       Net Receivables 
167,262
217,202
263,773
305,148
289,759
333,255
300,231
286,076
257,855
287,323
304,337
300,966
296,498
337,796
324,021
337,160
280,171
291,925
300,105
331,380
255,233
271,420
315,487
339,161
274,084
300,961
327,909
434,887
343,817
403,747
412,695
625,758
492,009
458,976
608,115
870,823
662,854
570,322
575,153
779,086
513,362
423,504
408,259
477,652
408,784
393,259
374,787
387,108
482,540
622,808
665,540
681,815
414,474
485,826
455,011
514,023
514,023455,011485,826414,474681,815665,540622,808482,540387,108374,787393,259408,784477,652408,259423,504513,362779,086575,153570,322662,854870,823608,115458,976492,009625,758412,695403,747343,817434,887327,909300,961274,084339,161315,487271,420255,233331,380300,105291,925280,171337,160324,021337,796296,498300,966304,337287,323257,855286,076300,231333,255289,759305,148263,773217,202167,262
       Other Current Assets 
32,296
18,239
25,044
76,484
79,524
22,766
24,946
27,299
37,429
50,060
79,046
96,076
93,338
122,524
161,468
121,476
23,239
16,715
16,222
17,813
19,233
29,604
25,407
18,890
12,210
14,167
11,702
11,255
11,752
13,125
18,721
12,501
73,443
29,840
31,476
27,323
21,521
28,372
22,427
6,215
9,394
4,813
6,841
6,948
7,628
9,162
90,233
99,744
107,673
11,790
120,884
17,604
25,081
13,103
27,275
26,965
26,96527,27513,10325,08117,604120,88411,790107,67399,74490,2339,1627,6286,9486,8414,8139,3946,21522,42728,37221,52127,32331,47629,84073,44312,50118,72113,12511,75211,25511,70214,16712,21018,89025,40729,60419,23317,81316,22216,71523,239121,476161,468122,52493,33896,07679,04650,06037,42927,29924,94622,76679,52476,48425,04418,23932,296
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,821,854
2,808,739
2,789,969
2,808,808
2,928,344
2,954,689
3,005,648
3,027,743
3,056,785
3,095,900
3,124,658
3,174,165
3,211,950
3,225,824
3,259,419
3,346,446
3,463,750
3,481,810
3,566,417
3,683,337
3,683,3373,566,4173,481,8103,463,7503,346,4463,259,4193,225,8243,211,9503,174,1653,124,6583,095,9003,056,7853,027,7433,005,6482,954,6892,928,3442,808,8082,789,9692,808,7392,821,854000000000000000000000000000000000000
       Property Plant Equipment 
102,134
142,173
168,590
186,610
206,896
228,663
1,658,410
1,688,844
1,709,376
1,971,053
2,267,706
2,608,384
2,595,432
2,591,385
2,909,221
2,887,695
2,871,851
2,839,592
2,812,098
2,840,582
2,815,659
2,871,426
2,872,108
2,842,724
2,811,816
2,785,631
2,758,260
2,729,685
2,712,471
2,709,447
2,698,310
2,707,104
2,691,296
2,679,481
2,693,472
2,689,666
2,686,986
2,692,409
2,675,728
2,676,284
2,676,493
2,666,641
2,650,119
2,630,540
2,609,501
2,581,033
2,572,367
2,542,199
2,520,015
2,507,840
2,680,785
2,700,506
2,766,248
2,766,072
2,801,882
2,849,230
2,849,2302,801,8822,766,0722,766,2482,700,5062,680,7852,507,8402,520,0152,542,1992,572,3672,581,0332,609,5012,630,5402,650,1192,666,6412,676,4932,676,2842,675,7282,692,4092,686,9862,689,6662,693,4722,679,4812,691,2962,707,1042,698,3102,709,4472,712,4712,729,6852,758,2602,785,6312,811,8162,842,7242,872,1082,871,4262,815,6592,840,5822,812,0982,839,5922,871,8512,887,6952,909,2212,591,3852,595,4322,608,3842,267,7061,971,0531,709,3761,688,8441,658,410228,663206,896186,610168,590142,173102,134
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,100
30,100
30,100
30,100
30,100
30,100
30,100
36,100
36,100
36,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000036,10036,10036,10030,10030,10030,10030,10030,10030,10030,100000000000000000000000000000000
       Intangible Assets 
5,919
4,536
3,921
4,669
5,903
66,138
65,743
66,324
65,613
56,314
53,219
49,940
45,139
40,561
37,867
40,606
37,675
34,603
31,840
32,172
30,680
28,167
25,711
25,779
23,728
21,005
16,941
16,565
16,413
14,633
11,747
11,759
10,706
9,148
8,344
8,550
10,259
8,943
7,518
14,285
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000014,2857,5188,94310,2598,5508,3449,14810,70611,75911,74714,63316,41316,56516,94121,00523,72825,77925,71128,16730,68032,17231,84034,60337,67540,60637,86740,56145,13949,94053,21956,31465,61366,32465,74366,1385,9034,6693,9214,5365,919
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
551
512
453
438
59,560
58,194
56,057
54,158
52,250
50,559
48,118
46,717
44,987
43,100
41,469
39,311
37,461
35,333
33,522
31,483
31,48333,52235,33337,46139,31141,46943,10044,98746,71748,11850,55952,25054,15856,05758,19459,560438453512551000000000000000000000000000000000000
> Total Liabilities 
181,999
441,169
300,362
270,639
463,639
741,134
1,950,770
1,765,900
2,532,841
2,717,308
2,630,563
2,631,206
2,833,495
3,035,700
3,272,238
3,453,567
3,258,444
3,399,051
3,386,030
3,319,932
2,657,300
2,773,614
2,756,855
2,025,364
1,825,441
2,063,564
1,878,986
2,059,715
1,923,682
2,348,041
2,463,546
2,297,314
2,215,330
2,264,984
2,373,629
2,596,296
2,437,765
2,429,057
2,457,649
2,357,395
2,218,172
2,462,962
2,484,208
2,414,269
2,414,487
2,471,390
2,532,951
2,487,805
2,816,052
2,939,619
2,890,163
2,902,525
2,997,683
3,045,713
3,120,546
3,307,373
3,307,3733,120,5463,045,7132,997,6832,902,5252,890,1632,939,6192,816,0522,487,8052,532,9512,471,3902,414,4872,414,2692,484,2082,462,9622,218,1722,357,3952,457,6492,429,0572,437,7652,596,2962,373,6292,264,9842,215,3302,297,3142,463,5462,348,0411,923,6822,059,7151,878,9862,063,5641,825,4412,025,3642,756,8552,773,6142,657,3003,319,9323,386,0303,399,0513,258,4443,453,5673,272,2383,035,7002,833,4952,631,2062,630,5632,717,3082,532,8411,765,9001,950,770741,134463,639270,639300,362441,169181,999
   > Total Current Liabilities 
180,641
426,789
289,939
265,398
463,072
740,567
850,203
664,684
617,412
798,265
708,694
707,328
1,731,984
1,691,110
1,927,183
1,307,766
1,356,682
1,497,418
1,579,483
1,606,814
944,616
1,156,112
1,068,014
691,866
934,984
1,189,684
1,067,827
1,264,285
1,144,376
1,584,427
1,715,154
1,559,285
1,498,398
1,557,936
1,468,728
1,481,422
1,370,519
1,412,127
1,432,961
1,380,966
1,286,659
1,432,828
1,228,513
1,241,045
1,323,558
1,217,196
1,273,662
1,329,432
1,758,469
1,734,067
1,699,309
1,410,960
1,603,767
1,665,140
1,356,519
1,609,001
1,609,0011,356,5191,665,1401,603,7671,410,9601,699,3091,734,0671,758,4691,329,4321,273,6621,217,1961,323,5581,241,0451,228,5131,432,8281,286,6591,380,9661,432,9611,412,1271,370,5191,481,4221,468,7281,557,9361,498,3981,559,2851,715,1541,584,4271,144,3761,264,2851,067,8271,189,684934,984691,8661,068,0141,156,112944,6161,606,8141,579,4831,497,4181,356,6821,307,7661,927,1831,691,1101,731,984707,328708,694798,265617,412664,684850,203740,567463,072265,398289,939426,789180,641
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,563,652
1,460,784
1,671,590
62,330
62,330
62,330
62,330
57,958
85,042
951,234
816,221
963,664
866,241
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000866,241963,664816,221951,23485,04257,95862,33062,33062,33062,3301,671,5901,460,7841,563,652000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,563,652
1,460,784
1,671,590
62,330
62,330
62,330
62,330
57,958
85,042
951,234
816,221
963,664
866,241
793,258
890,734
808,956
828,981
892,297
686,113
798,127
869,715
1,205,662
1,069,237
1,132,614
775,683
895,171
1,034,134
885,810
1,109,964
1,109,964885,8101,034,134895,171775,6831,132,6141,069,2371,205,662869,715798,127686,113892,297828,981808,956890,734793,258866,241963,664816,221951,23485,04257,95862,33062,33062,33062,3301,671,5901,460,7841,563,652000000000000000000000000000
       Accounts payable 
98,563
173,685
142,989
110,750
166,250
169,481
212,752
154,110
129,608
119,402
132,290
116,639
120,008
213,357
183,320
73,866
105,973
129,724
148,055
170,209
158,831
155,855
140,192
129,232
97,191
138,252
158,787
188,765
182,365
191,404
174,494
144,818
146,913
173,470
196,651
162,842
181,579
184,535
177,557
149,036
199,949
164,057
149,037
147,165
164,289
169,817
176,420
151,987
162,707
188,239
186,555
180,118
175,360
133,063
124,681
147,685
147,685124,681133,063175,360180,118186,555188,239162,707151,987176,420169,817164,289147,165149,037164,057199,949149,036177,557184,535181,579162,842196,651173,470146,913144,818174,494191,404182,365188,765158,787138,25297,191129,232140,192155,855158,831170,209148,055129,724105,97373,866183,320213,357120,008116,639132,290119,402129,608154,110212,752169,481166,250110,750142,989173,68598,563
       Other Current Liabilities 
82,078
253,104
146,950
154,648
142,361
303,203
197,065
217,031
179,823
358,068
158,881
144,023
132,348
225,070
333,133
193,047
127,920
215,348
149,224
262,729
173,530
258,823
207,254
194,242
182,298
332,095
243,501
306,580
280,357
484,980
250,444
292,851
274,128
520,150
280,859
295,111
7,091
15,413
22,783
335,712
278,315
358,474
247,807
247,737
249,484
345,140
282,766
299,595
381,973
470,820
375,849
452,222
7,965
487,528
6,723
8,072
8,0726,723487,5287,965452,222375,849470,820381,973299,595282,766345,140249,484247,737247,807358,474278,315335,71222,78315,4137,091295,111280,859520,150274,128292,851250,444484,980280,357306,580243,501332,095182,298194,242207,254258,823173,530262,729149,224215,348127,920193,047333,133225,070132,348144,023158,881358,068179,823217,031197,065303,203142,361154,648146,950253,10482,078
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,067,246
1,016,930
1,024,688
976,429
931,513
1,030,134
1,255,695
1,173,224
1,090,929
1,254,194
1,259,289
1,158,373
1,057,583
1,205,552
1,190,854
1,491,565
1,393,916
1,380,573
1,764,027
1,698,372
1,698,3721,764,0271,380,5731,393,9161,491,5651,190,8541,205,5521,057,5831,158,3731,259,2891,254,1941,090,9291,173,2241,255,6951,030,134931,513976,4291,024,6881,016,9301,067,246000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,563,652
-1,460,784
-1,671,590
-62,330
-62,330
-62,330
-62,330
-57,958
-85,042
-945,082
-811,082
-959,615
-859,578
14,425
13,393
11,999
10,593
9,385
8,272
6,941
5,584
4,323
2,969
8,141
9,526
23,585
25,095
23,435
20,235
20,23523,43525,09523,5859,5268,1412,9694,3235,5846,9418,2729,38510,59311,99913,39314,425-859,578-959,615-811,082-945,082-85,042-57,958-62,330-62,330-62,330-62,330-1,671,590-1,460,784-1,563,652000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
393
416
821
857
950
742
732
728
630
505
514
504
558
5585045145056307287327429508578214163934440000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,218
84,791
121,011
157,504
191,404
225,902
261,172
282,968
327,708
358,855
392,720
431,845
0
535,288
564,491
0
0
00564,491535,2880431,845392,720358,855327,708282,968261,172225,902191,404157,504121,01184,79135,218000000000000000000000000000000000000000
> Total Stockholder Equity
538,248
595,627
636,980
1,016,422
1,058,029
977,095
1,025,612
1,085,081
1,114,937
961,346
987,667
1,000,969
1,021,548
1,024,724
1,059,081
1,070,677
1,075,807
1,000,074
1,015,664
1,347,172
1,367,214
1,330,455
1,369,252
2,541,880
2,554,219
2,464,929
2,513,668
2,586,816
2,469,252
2,033,999
2,028,328
2,077,602
2,095,065
1,893,442
1,923,745
1,991,237
2,005,784
1,934,542
1,946,844
2,042,577
2,080,490
1,953,530
2,007,945
2,065,627
2,092,115
1,983,735
2,019,308
2,069,349
1,973,330
2,017,678
2,041,956
2,072,425
1,941,982
1,953,747
1,953,730
1,986,032
1,986,0321,953,7301,953,7471,941,9822,072,4252,041,9562,017,6781,973,3302,069,3492,019,3081,983,7352,092,1152,065,6272,007,9451,953,5302,080,4902,042,5771,946,8441,934,5422,005,7841,991,2371,923,7451,893,4422,095,0652,077,6022,028,3282,033,9992,469,2522,586,8162,513,6682,464,9292,554,2192,541,8801,369,2521,330,4551,367,2141,347,1721,015,6641,000,0741,075,8071,070,6771,059,0811,024,7241,021,5481,000,969987,667961,3461,114,9371,085,0811,025,612977,0951,058,0291,016,422636,980595,627538,248
   Common Stock
278,844
362,356
362,356
399,516
399,516
399,516
439,468
439,468
439,468
439,468
439,468
439,468
439,468
439,468
439,468
439,468
439,468
439,468
439,468
514,468
514,468
514,468
514,468
634,468
634,468
634,468
634,468
634,468
634,468
634,468
594,468
594,468
594,468
594,468
594,468
594,468
594,468
595,008
595,008
596,698
605,358
615,218
615,218
617,558
619,633
621,953
622,358
622,888
622,888
606,022
606,240
606,870
0
0
0
0
0000606,870606,240606,022622,888622,888622,358621,953619,633617,558615,218615,218605,358596,698595,008595,008594,468594,468594,468594,468594,468594,468594,468634,468634,468634,468634,468634,468634,468634,468514,468514,468514,468514,468439,468439,468439,468439,468439,468439,468439,468439,468439,468439,468439,468439,468439,468399,516399,516399,516362,356362,356278,844
   Retained Earnings 
106,013
62,892
104,524
142,011
182,474
121,169
121,279
179,582
180,270
5,630
30,046
37,609
107,132
103,917
135,138
141,498
144,169
68,168
78,893
117,151
137,381
101,423
131,560
167,421
180,013
131,211
185,543
257,890
283,981
152,035
50,500
97,771
111,737
138,566
164,442
225,511
232,331
155,752
161,563
216,593
208,341
103,898
144,349
189,752
201,679
163,340
193,921
225,521
163,554
123,653
133,887
163,030
142,187
144,800
134,683
146,071
146,071134,683144,800142,187163,030133,887123,653163,554225,521193,921163,340201,679189,752144,349103,898208,341216,593161,563155,752232,331225,511164,442138,566111,73797,77150,500152,035283,981257,890185,543131,211180,013167,421131,560101,423137,381117,15178,89368,168144,169141,498135,138103,917107,13237,60930,0465,630180,270179,582121,279121,169182,474142,011104,52462,892106,013
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-138,141-138,141-138,141-138,141-138,141-367,105-138,1410000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
645
-8,290
-6,599
-6,687
-8,592
-10,250
-6,031
-6,763
-5,500
-2,934
-4,242
988
30,301
30,518
-14,375
-3,805
-5,848
-4,182
-15,739
-15,883
-3,142
6,294
-6,855
4,005
-108
0
0
0
0
0000-1084,005-6,8556,294-3,142-15,883-15,739-4,182-5,848-3,805-14,37530,51830,301988-4,242-2,934-5,500-6,763-6,031-10,250-8,592-6,687-6,599-8,290645000000000000000000000000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,755,567
Cost of Revenue-1,039,917
Gross Profit715,650715,650
 
Operating Income (+$)
Gross Profit715,650
Operating Expense-1,805,420
Operating Income-49,853-1,089,770
 
Operating Expense (+$)
Research Development242,338
Selling General Administrative523,165
Selling And Marketing Expenses0
Operating Expense1,805,420765,503
 
Net Interest Income (+$)
Interest Income4,319
Interest Expense-48,234
Other Finance Cost-0
Net Interest Income-43,915
 
Pretax Income (+$)
Operating Income-49,853
Net Interest Income-43,915
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-31,875-49,853
EBIT - interestExpense = -48,234
6,209
54,443
Interest Expense48,234
Earnings Before Interest and Taxes (EBIT)016,359
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-31,875
Tax Provision--38,406
Net Income From Continuing Ops6,5316,531
Net Income6,209
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net043,915
 

Technical Analysis of Bionime
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionime. The general trend of Bionime is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionime's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionime Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 71.20 < 73.30 < 73.70.

The bearish price targets are: 67.20.

Tweet this
Bionime Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionime Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionime Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionime Corp. The current macd is -0.72937562.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bionime price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bionime. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bionime price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bionime Corp Daily Moving Average Convergence/Divergence (MACD) ChartBionime Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionime Corp. The current adx is 16.73.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bionime shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bionime Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionime Corp. The current sar is 71.98.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bionime Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionime Corp. The current rsi is 47.61. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Bionime Corp Daily Relative Strength Index (RSI) ChartBionime Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionime Corp. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionime price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bionime Corp Daily Stochastic Oscillator ChartBionime Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionime Corp. The current cci is -36.05442177.

Bionime Corp Daily Commodity Channel Index (CCI) ChartBionime Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionime Corp. The current cmo is 4.71943667.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bionime Corp Daily Chande Momentum Oscillator (CMO) ChartBionime Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionime Corp. The current willr is -24.24242424.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bionime is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bionime Corp Daily Williams %R ChartBionime Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bionime Corp.

Bionime Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionime Corp. The current atr is 0.90049077.

Bionime Corp Daily Average True Range (ATR) ChartBionime Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionime Corp. The current obv is 503,243.

Bionime Corp Daily On-Balance Volume (OBV) ChartBionime Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionime Corp. The current mfi is 18.67.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bionime Corp Daily Money Flow Index (MFI) ChartBionime Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionime Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Bionime Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionime Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.605
Ma 20Greater thanMa 5070.720
Ma 50Greater thanMa 10071.314
Ma 100Greater thanMa 20074.033
OpenGreater thanClose69.700
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bionime with someone you think should read this too:
  • Are you bullish or bearish on Bionime? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionime? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bionime Corp

I send you an email if I find something interesting about Bionime Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Bionime Corp.

Receive notifications about Bionime Corp in your mailbox!